2 not yet recruiting, 1 completed, 1 recruiting. 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Crohn Disease and Ulcerative Colitis: new trials by email Literature Review of Crohn Disease and Ulcerative Colitis trials Research Report on Crohn Disease and Ulcerative Colitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bacillus Probiotic Spores in Supporting the Treatment of Chronic Inflammatory Bowel Disease RO, LiveSpo® DIA30, LiveSpo® COLON - Crohn Disease and Ulcerative Colitis | Not applicable | Recruiting | Anabio R&D | 150 | 2026-09-04 | 2026-10-28 |
| Post Operative Hospital at Home After Colorectal Surgery virtual Hospital at Home - Colo-rectal Cancer, Colo-rectal Surgery | Not applicable | Not yet recruiting | Nordsjaellands Hospital | 20 | 2025-12-15 | 2025-08-11 |
| Risankizumab for Fibrostenotic Crohn's Disease Treatment Ustekinumab, Risankizumab - Crohn Disease, Crohn Disease and Ulcerative Colitis | Phase 3 | Not yet recruiting | First Affiliated Hospital of Wenzhou Medical University | 260 | 2025-10-20 | 2025-09-16 |
| Evaluation of the Effectiveness of Kits Promonitor-IFX/ADL and Promonitor-Anti-IFX/ADL in Patients With IBD Use of the test for treatment optimization - Crohn Disease and Ulcerative Colitis | Completed | Hospital de Basurto | 209 | 2017-01-16 | 2024-10-30 |
Colitis, Ulcerative (4) · Crohn Disease (4) · Colonic Neoplasms (1) · Diverticulosis, Colonic (1) · Inflammatory Bowel Diseases (1)
Colitis (4) · Colonic Diseases (4) · Digestive System Diseases (4) · Gastroenteritis (4) · Gastrointestinal Diseases (4) · Intestinal Diseases (4) · Inflammatory Bowel Diseases (3) · Colorectal Neoplasms (1) · Digestive System Neoplasms (1) · Gastrointestinal Neoplasms (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1)
Ustekinumab (1) · risankizumab (1)
Anabio R&D (1) · First Affiliated Hospital of Wenzhou Medical University (1) · Hospital de Basurto (1) · Nordsjaellands Hospital (1)
Denmark (1) · Spain (1) · Vietnam (1)
Anh N T, Assoc.Prof. (1) · Anh TV Nguyen, Assoc.Prof. (1) · Khanh V Tran, Prof. (1) · Kristin J Steinthorsdottir, MD, Ph.d. (1)
PMID 25793197, PMID 25996176, PMID 26720180, PMID 26855812, PMID 28848511, PMID 29767705, PMID 29854599, PMID 31435168, PMID 32998068, PMID 39060735